Trials / Recruiting
RecruitingNCT07491952
Continuous Dual Aspiration Technique With Zoom System for Stroke
Clinical Evaluation of Continuous Dual Aspiration Technique With Zoom System for Stroke (ADAPT 2.0)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (estimated)
- Sponsor
- Imperative Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zoom System | Aspiration neurothrombectomy using Zoom System with Continuous Dual Aspiration Technique (CDAT) |
Timeline
- Start date
- 2026-03-24
- Primary completion
- 2030-03-31
- Completion
- 2030-06-01
- First posted
- 2026-03-25
- Last updated
- 2026-04-16
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07491952. Inclusion in this directory is not an endorsement.